Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis

Journal of Critical Care

Volumn 26, Issue 1, 2011, Pages 54-64

  Tschaikowsky, Klaus ^a   Hedwig Geissing, Monika ^a   Braun, Giovanni G ^a   Radespiel Troeger, Martin ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Population Based Cancer Registry Bavaria   (Germany)

Author keywords

C reactive protein (CRP); Interleukin 6 (IL 6); Multiple organ dysfunction; Outcome; Procalcitonin (PCT)

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN;

ACCURACY; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SEPSIS; SURVIVAL RATE; SURVIVOR;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEPSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 79551519906     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2010.04.011     Document Type: Article

References (30)

1. Sands K.E., Bates D.W., Lanken P.N., et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997, 278:234-240.
2. Alberti C., Brun-Buisson C., Goodman S.V., et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003, 168:77-84.
3. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
4. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
5. Knaus W.A., Wagner D.P., Draper E.A., et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991, 100:1619-1636.
6. Wunder C., Eichelbronner O., Roewer N. Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res 2004, 53:158-163.
7. Ugarte H., Silva E., Mercan D., et al. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999, 27:498-504.
8. Oberhoffer M., Vogelsang H., Russwurm S., et al. Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 1999, 37:363-368.
9. Viallon A., Guyomarc'h S., Marjollet O., et al. Can emergency physicians identify a high mortality subgroup of patients with sepsis: role of procalcitonin. Eur J Emerg Med 2008, 15:26-33.
10. Clec'h C., Ferriere F., Karoubi P., et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004, 32:1166-1169.
11. Selberg O., Hecker H., Martin M., et al. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 2000, 28:2793-2798.
12. Clec'h C., Fosse J.P., Karoubi P., et al. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006, 34:102-107.
13. Tschaikowsky K., Hedwig-Geissing M., Schiele A., et al. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med 2002, 30:1015-1023.
14. Harbarth S., Holeckova K., Froidevaux C., et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001, 164:396-402.
15. Novotny A., Emmanuel K., Matevossian E., et al. Use of procalcitonin for early prediction of lethal outcome of postoperative sepsis. Am J Surg 2007, 194:35-39.
16. Fritz H.G., Brandes H., Bredle D.L., et al. Post-operative hypoalbuminaemia and procalcitonin elevation for prediction of outcome in cardiopulmonary bypass surgery. Acta Anaesthesiol Scand 2003, 47:1276-1283.
17. Nobre V., Harbarth S., Graf J.D., et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008, 177:498-505.
18. Schmit X., Vincent J.L. The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 2008, 36:213-219.
19. Jensen J.U., Heslet L., Jensen T.H., et al. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006, 34:2596-2602.
20. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
21. Clopper C.J., Pearson E.S. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934, 26:404-413.
22. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
23. Reinhart K., Menges T., Gardlund B., et al. Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: the RAMSES Study. Crit Care Med 2001, 29:765-769.
24. Meisner M., Tschaikowsky K., Palmaers T., et al. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999, 3:45-50.
25. Gaini S., Koldkjaer O.G., Pedersen C., et al. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 2006, 10:R53.
26. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002, 323:17-29.
27. Castell J.V., Geiger T., Gross V., et al. Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur J Biochem 1988, 177:357-361.
28. Dahaba A.A., Hagara B., Fall A., et al. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 2006, 97:503-508.
29. Randolph A.G., Guyatt G.H., Richardson W.S. Prognosis in the intensive care unit: finding accurate and useful estimates for counseling patients. Crit Care Med 1998, 26:767-772.
30. Meisner M., Tschaikowsky K., Hutzler A., et al. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998, 24:680-684.